Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Intangibles (2011 - 2025)

Updated

Sinovac Biotech (SVA) reported Intangibles of $77.68 million for Q4 2025, down 36.6% from $122.58 million a year earlier.

Analysis

Sinovac Biotech (SVA) Intangibles (2011 - 2025) Analysis & Trends

Dating back to Q4 2011, Sinovac Biotech's Intangibles record includes 8 quarters.

  • Intangibles has a five-year compound annual growth rate of 121.0% (FY2020 to FY2025).
  • By year, Intangibles came in at $122.58 million in FY2024, $8.52 million in FY2023 (-12.2%), $9.7 million in FY2022 (+555.3%) and $1.48 million in FY2021 (+0.4%).
  • The Q4 2025 figure ranks as the lowest quarterly Intangibles since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,171.37 Bn 1,139.96 Bn 19.71 Bn 18.11 Bn
2 Johnson & Johnson 645.23 Bn 565.09 Bn 17.30 Bn 46.65 Bn
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn 49.14 Bn
4 Merck 361.34 Bn 315.71 Bn 12.21 Bn 24.98 Bn
5 Novartis Ag 302.82 Bn 266.81 Bn 11.24 Bn 42.07 Bn
6 Astrazeneca 267.91 Bn 241.60 Bn 12.86 Bn 37.72 Bn
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn 20.49 Bn
8 Gilead Sciences 193.55 Bn 167.74 Bn 6.22 Bn 14.03 Bn
9 Pfizer 172.05 Bn 118.70 Bn 10.94 Bn 47.05 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn - 77.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 77.68 Mn
Dec 31, 2024 122.58 Mn
Dec 31, 2023 8.52 Mn
Dec 31, 2022 9.70 Mn
Dec 31, 2021 1.48 Mn
Dec 31, 2020 1.47 Mn
Dec 31, 2012 1.15 Mn
Dec 31, 2011 1.34 Mn
API Access

Sinovac Biotech Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=SVA&period=max&api_key=YOUR_API_KEY